chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Began smelling a foul odor 2 days following the vaccination, along with mild loss of smell and taste.
sore arm; Mild headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and HEADACHE (Mild headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and HEADACHE (Mild headache). At the time of the report, PAIN IN EXTREMITY (sore arm) and HEADACHE (Mild headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported No Treatment medications were reported.
Received ZOSTAVAX 3/25/10. On 3/29/10 with numbness & L low rib cage area -> progressed to L back. 4/2/10 appearance of rash / blistery- L ribs and L back. Appt. this AM 4/5/10 to verify blistery rash and discomfort.
Inflammation; erythema; pain; itching; warmth of area. General malaise; headache; nausea; weakness which started 10 days after vaccination. Pt seen at ER and treated with Antibiotics. (also fever and chills).
No adverse effects. Patient was contacted by MD notifying patient that vaccine used was in fridge for 24 hours and was not discarded after 12 hours from being drawn up. Patient had no complaint of adverse reactions.
expired ACTHIB administered to a patient with no reported AE; Initial information was received on 16-Dec-2022 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves 14 months old male patient who reported that expired acthib administered to a patient with no reported ae after receiving hib (prp/t) vaccine [ACT-HIB].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included measles vaccine LIVE (ENDERS-EDMONSTON), MUMPS VACCINE LIVE (JERYL LYNN), rubella vaccine LIVE (WISTAR RA 27/3), VARICELLA zoster vaccine live (OKA/MERCK) (Proquad); hepatitis a vaccine (HEPATITIS A); and pneumococcal vaccine CONJ 13V (CRM197) (Prevnar 13).  On 15-Dec-2022, the patient received a dose of 0.5 ml suspect hib (prp/t) vaccine (Powder and solvent for solution for injection) (Frequency: once, lot UJ611AA) via intramuscular route in the right thigh. for prophylactic vaccination(immunization)  On 15-Dec-2022 the patient developed a non-serious event of expired acthib administered to a patient with no reported ae (expired product administered) (latency: same day) following the administration of hib (prp/t) vaccine.  Action taken : not applicable.  It was not reported if the patient received a corrective treatment for the event (expired Acthib administered to a patient with no reported AE).  At time of reporting, the outcome was Not Recovered for the event expired acthib administered to a patient with no reported ae.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
TERRIBLE HEADACHE, NAUSEA, BODY ACHES, SINUS CONGESTION
no adverse event; Monovalent ages 6-11 vaccine administered instead of Bivalent vaccine / instead of receiving Moderna COVID-19 Vaccine, Bivalent, they got Moderna COVID-19 vaccine with Blue Capped Purple-Bordered; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Monovalent ages 6-11 vaccine administered instead of Bivalent vaccine / instead of receiving Moderna COVID-19 Vaccine, Bivalent, they got Moderna COVID-19 vaccine with Blue Capped Purple-Bordered) and NO ADVERSE EVENT (no adverse event) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR6965B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Oct-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Monovalent ages 6-11 vaccine administered instead of Bivalent vaccine / instead of receiving Moderna COVID-19 Vaccine, Bivalent, they got Moderna COVID-19 vaccine with Blue Capped Purple-Bordered). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Monovalent ages 6-11 vaccine administered instead of Bivalent vaccine / instead of receiving Moderna COVID-19 Vaccine, Bivalent, they got Moderna COVID-19 vaccine with Blue Capped Purple-Bordered) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Monovalent ages 6-11 vaccine administered instead of Bivalent vaccine / instead of receiving Moderna COVID-19 Vaccine, Bivalent, they got Moderna COVID-19 vaccine with Blue Capped Purple-Bordered).    No concomitant product reported by reporter.  Seven patient received Moderna COVID-19 vaccine with Blue Capped Purple-Bordered (Ages 6-11 years Monovalent) instead of receiving Moderna COVID-19 Vaccine Bivalent.  No treatment medication reported by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 17-Oct-2022: Live Significant follow up included batch number and expiry date. On 17-Oct-2022: Live Significant Follow-up added. Patient identifiers updated.
Describe the adverse event(s), treatment, and outcome(s), if any: (symptoms, signs, time course, etc.) Had a rash that covered over 90% of my body. It was red and itchy and it stung. I was prescribed Clobetasol 0.5, Triamcinolone 0.1%. I was prescribed a high dose of Prednisone 90 mg steroids on May 3rd. The rash lasted about six weeks. Estimated due date for pregnancy 06/26/2021. Pregnancy was normal until I was put on the high dose of steroids I started having extra fluids.
On 3/26/21 at 13:30, 38 year old female received her first dose of Pfizer vaccine lot#8732  0.3 ml to right deltoid. At 13:39 Patient  noted pale in color, patient state ? I am going to pass out? staff assisted patient to the floor in supine position with her legs elevated  , Blood pressure monitored 98/62,  heart rate 120, 02 sat 100% on room air, resp 14. Throughout the episode patient remained verbally responsive , able to provide medical history such as Lime Disease, Gout, interstitial Cystitis, Babesia, Chronic Migraine, Patient endorse allergy to Anapramine . As per patient, was recently hospitalized for picc line infection, which she received vancomycin antibiotic and she was discharge form the hospital on Monday, March 22, 2021. At 1353 Blood pressure rechecked 102/72 HR 106, 02 sat 100%, resp 16, patient asymptomatic at this while she remained in supine position.  At 1354 when assisted to a sitting position Blood pressure decrease to 92/62, heart rate 120, o2 sat 100% on roomair , also patient complaining of feeling dizzy. At 1356 pm Patient returned to supine position with her legs elevated. At 14:01 Rescue was called and alerted on the patient?s condition, patient remained alert oriented. Patient husband and kids in facility aware of patient condition. At 14:07 pm rescue attendants arrived to facility and took over patient care, vital sign as followed: BP 94/62, respiration 18 heart rate 112, o2 sat 98% on room air. Patient transported to hospital.
This spontaneous report derives from an internet website, where a patient's mother reported on her approximately 14-year-old daughter. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 02-OCT-2013 and 02-DEC-2013, the patient was vaccinated the first and the second dose of GARDASIL (exact dose, route, lot # and expiration date were not reported), respectively. Since 02-DEC-2013 (the second shot), the patient had never been the same and the symptoms started. Within a week, she went to the pediatrician's office with reports of constant dizziness and not feeling right. Symptoms were subtle at first, but then there were more and they were more severe. The patient was seen by a neurologist who believed that the vaccine caused an autoimmune "avalanche that triggered the Lyme disease front and center". The reporter stated that many of the symptoms of Lyme disease were the same for autoimmune issues and GARDASIL. The patient had legs, arms, back and neck pain. She also experienced blood pressure drop when standing and tachycardia. The reporter stated it was getting to be postural orthostatic tachycardia syndrome (POTS). The patient also developed Pediatric Acute-onset Neuropsychiatric Syndrome (PANS). The patient was not in school but in homebound program at that moment. The reporter also mentioned that her daughter was treated in the emergency room (ER) on 07-FEB-2015 with an intravenous (IV) "cocktail" to relieve the pain and nausea. They were considering the IV immunoglobulin therapy. Therapy with GARDASIL was discontinued (the patient did not receive the third dose). Outcome of the events was not reported. The patient's mother felt that the events were related to the therapy with GARDASIL. This is one of several reports received from the same source. Additional information has been requested.
Swelling with an itchy red circle around the injection site. Itching began approx 6 hours after receiving the injection. Redness and itching more prominent 48 hours after receiving the vaccine. This is my second vaccine, I did not have a reaction to the first. 2nd injection was given on the left side instead of the right.
Patient states that the day after she had the second vaccine, she experienced a lump on her neck opposite the side of the vaccine. She began experiencing swelling in her lymph nodes under her arms/near the breast area.
Little bit of pain in the arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: Little bit of pain in the arm). The outcome of the pain in arm was resolved (duration 3 days).   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm to be related to Shingles vaccine.   Linked case(s) involving the same patient:  US2023AMR104277   Additional Information: Receipt date: 31-JUL-2023 This case was reported by patient via interactive digital media. The patient stated that just two or three days of pain in the arm, that was all. The patient reported that he/she was fine with two doses, just a little bit of pain in the arm for about three days. Follow-up case was not provided as no contact details.; Sender's Comments:  US-GSK-US2023AMR104277:same patient, Case for second dose
I got the flu shot and was sicker; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media and transmitted to Sanofi on 04-Nov-2020.  This case involves an unknown age female patient who got the flu shot and was sicker (Illness), while she received vaccine INFLUENZA VACCINE.  Medical history, medical treatments, vaccinations, concomitant medications and family history were not provided.   On an unknown date, patient reported that she never got flu shots and was never got sick but on an unknown date 6 years ago patient received the dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (lot number unknown) via unknown route in unknown administration site for prophylactic vaccination and was sicker (than a dog) for four days (Illness).   No relevant laboratory tests were reported.   It was not reported if the patient received a corrective treatment.  Event outcome was reported as Unknown for Illness.  There will be no information regarding batch number for the case.
2nd Appointment Unavailable/received the 1st dose on 23Jan2021 and she received the 2nd dose on 06Mar2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Appointment Unavailable/received the 1st dose on 23Jan2021 and she received the 2nd dose on 06Mar2021) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027LZ0A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Appointment Unavailable/received the 1st dose on 23Jan2021 and she received the 2nd dose on 06Mar2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Appointment Unavailable/received the 1st dose on 23Jan2021 and she received the 2nd dose on 06Mar2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow up received on 20-Jul-2021 Contains 2nd dosage date.
dementia; cannot walk; COVID-brain; This spontaneous case was reported by a consumer and describes the occurrence of DEMENTIA (dementia) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DEMENTIA (dementia) (seriousness criterion medically significant), GAIT DISTURBANCE (cannot walk) and COVID-19 (COVID-brain). At the time of the report, DEMENTIA (dementia), GAIT DISTURBANCE (cannot walk) and COVID-19 (COVID-brain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product was reported.   On an unspecified date, SARS-CoV-2 test was positive.  No treatment information was reported.  Very limited information regarding these events has been provided at this time. Patient declined further contact; Sender's Comments: Very limited information regarding these events has been provided at this time. Patient declined further contact
dose reconstituted with saline solution; received dose with saline solution; This case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 61-year-old female patient who received Herpes zoster (Shingrix) (batch number 92C34, expiry date 4th June 2022) for prophylaxis.   On 28th September 2021, the patient received Shingrix. On 28th September 2021, unknown after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional information was provided as follows: The patient who might have received a dose of Shingrix reconstituted with saline solution instead the approved diluent, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The reporter was not completely sure but was asking for information about this. The reporter consented to follow up.
pt woke early AM c/o sore arm;mom noticed swelling, redness;child ran t101;cont to swell became red, warm to touch;mom also stated there was an additional welt @ site of inj;the swelling was from shoulder to elbow; red welt 21APR99;
p/pt recv vax 4/26 & 27 temp 101, 4/28/99 devel rash over whole body. followed by massive swelling of lymph glands. glands in groin area & inner thighs swelled also under arms & neck. benadryl prescribed for 5 days
Headache, Myalgia, Fever, stiff arm, fatigued, and loss of appetite
on and off for a week after my vaccination my arms would turn red and become very itchy; on and off for a week after my vaccination my arms would turn red and become very itchy; This is a spontaneous report from a contactable consumer (patient). A 20-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (at 20-years age)  as UNKNOWN, SINGLE DOSE  for covid-19 immunisation. Medical history included pulmonary valve stenosis, mitral valve incompetence, aortic valve incompetence, eczema mild eczema (almost never flares up on my forearms  I believe these recent rashes were caused by the vaccine) from an unknown date and unknown if ongoing. Concomitant medication(s) included fluoxetine hydrochloride (PROZAC) for unspecified indication; desogestrel, ethinylestradiol (APRI) taken for contraception (birth control), within 2 weeks of vaccination. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. On an unspecified date, the patient experienced on and off for a week after my vaccination my arms would turn red and become very itchy. It was not constant and it was mitigated by soothing moisturizer. No treatment received for the events. Outcome of events was resolved on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
ITCHY RASH ON BODY INCLUDING LEG AND FACE; This spontaneous report received from a patient concerned a 52 year old female. The patient's weight was 130 pounds, and height was not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, treatment medications included: steroids. On 11-APR-2021, the subject experienced itchy rash on body including leg and face. On 13-APR-2021, treatment medications included: steroids. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of itchy rash on body including leg and face was not reported. This report was non-serious.
post vaccine pt stated his heart started fluttering ,his hand and fingers started to tingle and mouth felt dry. Pt was given water and observed . After laying on the stretcher for a while patient stated he was feeling  better.  Patient was released at 0950 and escorted to south entrance . Vitals as follows:  0930 BP:135/84 HR 100 RR 20 SpO2 99 0935 BP 138/68 HR 80 RR 20 SpO2 99 0942 BP 116/71 HR 88 RR 18 SpO2 99
1st Dose March 2, 2021: No reaction 2nd Dose March 23, 2021: Severe Skin Disturbance Burning inside my hands, fingers, Face, Neck Unbearable pain from the burning and blisters/forearms Blisters would form from the inside of my body's burning to the outside then pop and bleed. Symmetrical pattern on both sides of my body.  My severe skin Disterbance was symmetrical Rheumatologist Visit: Many appointments and Medical tests to eliminate causes for my burning and blistering rash and reaction after the Covid Pfizer 2nd vaccine Burning and Blistering Pain Unbearable Urgent Care Visit: Buring and Blistering Pain Unbearable Dermatologist Visit: Many appointments and Medical tests to determine the cause of the intense burning and blistering with unbearable pain. after the 2nd Pzizer Covid Shot on March 23, 2021 I broke out on my face first, then Neck then hands and forearms on March 29, 2021. Ears and Ankles started but never as severe as the rest.
Patient felt faint (saw tunnel vision)  patient immediately returned to pharmacy and sat for 15-20 min patient was offered water and cookies.  After the resting time, patient felt fine. Advised patient to come back to pharmacy if he felt faint again.
Severe headache, vomiting, muscle weakness high fever. Arm pain, very lethargic most of the next day. Was unable to make it to bathroom without assistance. 18 to 20 hours later still have the head ache and muscle weakness. am able to walk to bathroom unassisted. Slowly returning to normal. My whole body was weak and aching. Like the worst flu you've had .This started about 6 to 9 hours after the second injection and lasted over night with a high fever in the middle of the night and most of the next day.  At around 10:22 pm the symptoms have begun to subside.
Neither of them received the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Neither of them received the second dose) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Neither of them received the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Neither of them received the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was reported
10/16/13 - Noted rash on upper left inner thigh appearing like bites - rash was itchy. 7 pm. Rash on lower leg 1 onto back. (L) arm was swollen - but no rash on arm. 10/17/13 Rash around FLUZONE injection site and onto neck. (Afebrile).
Severe headache, nausea, vomiting, upset stomach, chills without fever, unable to sleep